This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Apr;49(4):321-325.

doi: 10.1016/j.dld.2017.01.159. Epub 2017 Jan 21.

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game"

Francesco Paolo Russo¹, Savino Bruno², Fabio Farinati³

Affiliations

Affiliations

¹ Section of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
² Humanitas University and IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
³ Section of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy. Electronic address: fabio.farinati@unipd.it.

PMID: 28187979
DOI: 10.1016/j.dld.2017.01.159

Editorial

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game"

Francesco Paolo Russo et al. Dig Liver Dis. 2017 Apr.

. 2017 Apr;49(4):321-325.

doi: 10.1016/j.dld.2017.01.159. Epub 2017 Jan 21.

Authors

Francesco Paolo Russo¹, Savino Bruno², Fabio Farinati³

Affiliations

¹ Section of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
² Humanitas University and IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
³ Section of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy. Electronic address: fabio.farinati@unipd.it.

PMID: 28187979
DOI: 10.1016/j.dld.2017.01.159

No abstract available

PubMed Disclaimer

Comment on

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J. Reig M, et al. J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27084592

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations